Bio View (Israel) Performance

BIOV Stock  ILS 29.00  0.70  2.36%   
The firm shows a Beta (market volatility) of 1.68, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bio View will likely underperform. Bio-View has an expected return of -0.22%. Please make sure to confirm Bio-View treynor ratio, potential upside, and the relationship between the total risk alpha and maximum drawdown , to decide if Bio-View performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Bio View has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Begin Period Cash Flow17.2 M
Total Cashflows From Investing Activities-740 K
  

Bio View Relative Risk vs. Return Landscape

If you would invest  3,310  in Bio View on December 30, 2023 and sell it today you would lose (410.00) from holding Bio View or give up 12.39% of portfolio value over 90 days. Bio View is generating negative expected returns and assumes 2.9263% volatility on return distribution over the 90 days horizon. Simply put, 25% of stocks are less volatile than Bio, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Bio View is expected to under-perform the market. In addition to that, the company is 5.11 times more volatile than its market benchmark. It trades about -0.08 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.24 per unit of volatility.

Bio View Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio View's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bio View, and traders can use it to determine the average amount a Bio View's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.076

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBIOV

Estimated Market Risk

 2.93
  actual daily
25
75% of assets are more volatile

Expected Return

 -0.22
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average Bio View is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio View by adding Bio View to a well-diversified portfolio.

Bio View Fundamentals Growth

Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio View, and Bio View fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.

About Bio View Performance

To evaluate Bio-View Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Bio View generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Bio Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Bio-View market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Bio's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.

Things to note about Bio-View performance evaluation

Checking the ongoing alerts about Bio View for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio-View help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Bio-View generated a negative expected return over the last 90 days
About 52.0% of the company shares are held by company insiders
Evaluating Bio View's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Bio View's stock performance include:
  • Analyzing Bio View's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio View's stock is overvalued or undervalued compared to its peers.
  • Examining Bio View's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Bio View's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio View's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Bio View's stock. These opinions can provide insight into Bio View's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Bio View's stock performance is not an exact science, and many factors can impact Bio View's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio View. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Bio Stock analysis

When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Please note, there is a significant difference between Bio View's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio View is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio View's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.